Strong candidate for single-dose malaria cure identified

Sep 10, 2012 Comments Off on Strong candidate for single-dose malaria cure identified by

A recently-discovered compound – named MMV390048 – from the aminopyridine class not only has the potential to become part of a single-dose cure for all strains of malaria, but might also be able to block transmission of the parasite from person to person, according to a research collaboration involving the Medicines for Malaria Venture (MMV), based in Switzerland, and the Drug Discovery and Development Centre (H3-D) at UCT, directed by founder Professor Kelly Chibale FRSSAf.
Kelly Chibale

On the basis of initial results it was selected by Medicines for Malaria Venture (MMV Website) for further development – making it the first compound researched on African soil to enter preclinical development in partnership with MMV.

For more information go to :  UCT Monday Paper of 3 September

Mrs Naledi Pandor, Minister of Science and Technology said  “The discovery that we announce today is a significant victory in the battle to alleviate the burden of disease in Africa. Clearly the war on disease is not yet won but I am excited by the role that our excellent scientists have played in finding a potential single-dose cure for malaria and possibly preventing its transmission. This is evidence both of top science undertaken in South Africa and also of the power of continental and international scientific collaboration in addressing the societal challenges of our time.” Full text at All Africa

 

Notice Board

About the author

The author didnt add any Information to his profile yet
Comments are closed.